These include direct effects on tumor cells by cytokines produced by CD4+ T cells such as IFN-γ, TNF-α, and IL-2, modulation of DCs and other antigen presenting cells in the tumor microenvironment as well as direct killing of tumor cells by cytolytic CD4+ cells. The gene discussed is IL2; the disease is neoplasm.